Targeting SLITRK4 by Systemic Delivery of siRNA Using Lipid‐Polymer Hybrid Nanoparticles (NPs) for CRC Liver Metastasis Therapy. The gene discussed is SLITRK4; the disease is colorectal carcinoma.